AlivaMab Discovery Services (ADS) Announces Agreement with Tanabe Research Laboratories USA
Breakthrough Drugs
Begin Here
Let our experts in therapeutic antibody discovery be your experts
Delivering fully human therapeutic antibodies that meet or exceed your target product profile.
Recent News
Resources
News
June 3, 2020
AlivaMab Discovery Services (ADS) Announces Agreement with Tanabe Research Laboratories USA
READ MOREWebinar
Begin with the End in Mind:
Selection of an Antibody Discovery Platform
How the choice of therapeutic antibody discovery platform can impact downstream success in development and the market.
WATCHCorporate Fact Sheet
DOWNLOADInterview
Nature speaks to Larry Green, CEO
Harnessing platform technology and expertise to fuel antibody drug discovery
DOWNLOAD
